• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Diarrhea (1811); Inflammation (1932); Pain (1994); Discomfort (2330); Dysuria (2684); Dyspareunia (4505); Urinary Incontinence (4572); Insufficient Information (4580)
Event Date 11/28/2018
Event Type  Injury  
Manufacturer Narrative
Date of event was approximated to (b)(6) 2018, first bsc aware date, as no event date was reported.The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(6).(b)(4).The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an obtryx device was implanted into the patient during a procedure performed on (b)(6) 2018 for the treatment of stress urinary incontinence and pelvic organ prolapse.After, and as a result of the implantation of the medical device, the patient has suffered serious bodily injuries, including, but not limited to, urinary problems, pain when urinating, vaginal and pelvic pain, and dyspareunia and other injuries similar to the ones described in the fda's public health advisory of (b)(6) 2008 reportedly, the patient has experienced significant mental and physical pain and suffering, and has sustained severe and permanent injury.
 
Manufacturer Narrative
Additional information: blocks a3, b5, h6: patient codes and h6: impact codes.Correction to blocks e1: initial reporter title and b3 (below).Block b3 date of event: date of event was approximated to november 28, 2018, implant date, as no event date was reported.Blocks d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block e1: additional contacts: (b)(6).Attorney for plaintiff.Of counsel: (b)(6).Block h6: patient codes e2330, e1405, e1301, e2401, e2326 and e2101 capture the reportable events of pain, dyspareunia, dysuria, and urinary problems, permanent injury, other injuries, cystitis and adhesions impact code f1901 captures the reportable event of urethrolysis.Block h10: the complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an obtryx device was implanted into the patient during a procedure performed on (b)(6), 2018 for the treatment of stress urinary incontinence and pelvic organ prolapse.After, and as a result of the implantation of the medical device, the patient has suffered serious bodily injuries, including, but not limited to, urinary problems, pain when urinating, vaginal and pelvic pain, and dyspareunia and other injuries similar to the ones described in the fda's public health advisory of (b)(6), 2008.Reportedly, the patient has experienced significant mental and physical pain and suffering, and has sustained severe and permanent injury.Additional information received on march 23, 2022: on (b)(6), 2018, the patient presented for a post-operative follow up.The patient was reported to be a little better after her tvt procedure.However, she complained of diarrhea.She was still smoking at that time.Physical examination revealed no abnormalities.She was advised to return or call if the symptoms worsen or persist.Her medical history included colorectal cancer with colorectal resection and status post radiation; radiation cystitis with complicated incontinence.On (b)(6), 2019, the patient had cystoscopy and urethrolysis.During the procedure, it was noted that the anterior vaginal wall was thickened and densely adherent to the urethra.A very little tissue existed between the vaginal mucosa and the urethra.The sling was freed up in the midline and was incised on both sides, completely freeing up the urethra.Preoperative and postoperative diagnoses included history of colorectal cancer with colorectal resection and status post radiation; radiation cystitis with complicated incontinence; and status post tvt sling with ongoing incontinence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key11662290
MDR Text Key246430497
Report Number3005099803-2021-01496
Device Sequence Number1
Product Code OTN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040787
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/16/2021
Initial Date FDA Received04/13/2021
Supplement Dates Manufacturer Received03/23/2022
Supplement Dates FDA Received04/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age42 YR
Patient SexFemale
-
-